Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

178 Press Releases
DateTitleCompany
23 Apr 17 Lilly to Present Data for Galcanezumab for the Prevention of Migraine at the American Academy of Neurology (AAN) Annual Meeting Eli Lilly and Company,
Published by
PharmiWeb.com
14 Apr 17 U.S. FDA Issues Complete Response Letter for Baricitinib Eli Lilly and Company,
Published by
PR Newswire
11 Apr 17 Lilly Confirms Date and Conference Call for First-Quarter 2017 Financial Results Announcement Eli Lilly and Company,
Published by
PR Newswire
04 Apr 17 Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students Eli Lilly and Company,
Published by
PR Newswire
24 Mar 17 Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017 Eli Lilly and Company,
Published by
PR Newswire
23 Mar 17 Lilly and the William Sansum Diabetes Center announce a five-year research collaboration Eli Lilly and Company,
Published by
PharmiWeb.com
28 Feb 17 Lilly to Present New Data for Taltz® (ixekizumab) in Psoriasis and Psoriatic Arthritis at the American Academy of Dermatology (AAD) Annual Meeting Eli Lilly and Company,
Published by
PR Newswire
09 Feb 17 Lilly To Present At Leerink Partners Global Healthcare Conference Eli Lilly and Company,
Published by
PR Newswire
02 Feb 17 Japan IP High Court Rules In Lilly's Favor On Alimta Vitamin Regimen Patents Eli Lilly and Company,
Published by
PR Newswire
13 Jan 17 U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment Eli Lilly and Company,
Published by
PR Newswire
11 Jan 17 Lilly and Merck Expand Immuno-Oncology Collaboration Eli Lilly and Company,
Published by
PharmiWeb.com
06 Jan 17 Lilly to Adjust Organization and Leadership Structure to Better Align with Growth Opportunities Eli Lilly
05 Jan 17 Lilly to Adjust Organization and Leadership Structure to Better Align with Growth Opportunities Eli Lilly and Company,
Published by
PR Newswire
15 Dec 16 BASAGLAR® (insulin glargine injection 100 units/mL), A Long-Acting Basal Insulin, Is Now Available in U.S. Eli Lilly and Company; Boehringer Ingelheim,
Published by
PR Newswire
09 Dec 16 Lilly and AstraZeneca to Develop Second Potentially Disease-Modifying Treatment for Alzheimer's Disease Eli Lilly and Company,
Published by
PR Newswire
22 Nov 16 Survey Reveals Most People Don't Know Heart Disease Is the No. 1 Killer of People with Type 2 Diabetes Boehringer Ingelheim and Eli Lilly and Company,
Published by
PR Newswire
14 Nov 16 Baricitinib Demonstrates Early Response Compared to Placebo and Significant Improvement Compared to Adalimumab in Patient-Reported Outcomes Eli Lilly and Company,
Published by
PR Newswire
14 Nov 16 New Analyses of Phase 3 Trials Show Improvements in Rheumatoid Arthritis Symptoms Following Treatment with Baricitinib Across Diverse Population of Patients Eli Lilly and Company,
Published by
PR Newswire
13 Jul 16 Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer Eli Lilly and Company,
Published by
PR Newswire
21 Jul 16 Diversity of Lilly's Alzheimer's Disease Pipeline Showcased at the Alzheimer's Association International Conference® 2016 (AAIC® 2016) Eli Lilly and Company,
Published by
PR Newswire
23 Jun 16 Diabetes Scholars Foundation Announces 2016 Scholarship Recipients Eli Lilly and Company,
Published by
PR Newswire
31 Aug 16 Jamere Jackson Elected to Lilly Board of Directors Eli Lilly and Company,
Published by
PharmiWeb.com
21 Jul 16 U.S. FDA expands indication for type 2 diabetes treatment Synjardy® (empagliflozin/metformin hydrochloride) to include treatment-naïve adults Eli Lilly ,
Published by
PharmiWeb.com
21 Jul 16 Diversity of Lilly's Alzheimer's Disease Pipeline Showcased at the Alzheimer's Association International Conference® 2016 (AAIC® 2016) Eli Lilly ,
Published by
PharmiWeb.com
22 Aug 16 Lilly and AstraZeneca Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer's Disease Eli Lilly and Company,
Published by
PR Newswire
11 Oct 16 Leading Experts Warn Global Goal to Cure or Treat Alzheimer's Disease By 2025 is at Risk, Offer Solutions to Adjust Course Eli Lilly and Company,
Published by
PR Newswire
31 Oct 16 New Edition of Online Tool to Measure Cancer Progress to Launch at World Cancer Congress Eli Lilly ,
Published by
PharmiWeb.com
11 Oct 16 Lilly to Participate in Credit Suisse 2016 Healthcare Conference Eli Lilly and Company,
Published by
PR Newswire
04 Oct 16 Lilly Confirms Date And Conference Call For Third-Quarter 2016 Financial Results Announcement Eli Lilly and Company,
Published by
PR Newswire
05 Oct 16 Lilly Highlights Advancements in its Oncology Portfolio with New Data at ESMO 2016 Eli Lilly and Company,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.